News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

DBV Technologies Elects George Horner as Non-executive Chairman of the Board of Directors to Advance the Clinical Development of VIASKIN® Peanut, the World’s First Epicutaneous Skin Patch for Desensitization of Peanut Allergy


1/18/2011 10:27:36 AM

PARIS--(BUSINESS WIRE)--DBV Technologies, an emerging biotechnology company, announced today that its board of directors has elected George F. Horner III as non-executive chairman, effective immediately.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES